Study of MEDI 507 in the Treatment of Pediatric Patients

NCT00813618 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft Versus Host Disease

Interventions

DRUG: MEDI-507
DRUG: MEDI-507
DRUG: MEDI-507

Sponsor

MedImmune LLC